Key statistics
As of last trade Personalis Inc (04X:FRA) traded at 6.83, -30.07% below its 52-week high of 9.76, set on Jan 23, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 6.83 |
|---|---|
| High | 6.83 |
| Low | 6.83 |
| Bid | 6.83 |
| Offer | 7.21 |
| Previous close | 6.75 |
| Average volume | 1.53k |
|---|---|
| Shares outstanding | 88.80m |
| Free float | 61.03m |
| P/E (TTM) | -- |
| Market cap | 729.08m USD |
| EPS (TTM) | -0.8761 USD |
Data delayed at least 15 minutes, as of Feb 16 2026 07:19 GMT.
More ▼
Press releases
- Personalis to Announce Fourth Quarter and Full Year 2025 Financial Results
- Personalis Receives Medicare Coverage for NeXT Personal® in Lung Cancer Surveillance
- Personalis Announces New Publication Expanding Evidence for Ultrasensitive ctDNA Monitoring of Cancer Immunotherapy Response Across Solid Tumors
- Personalis to Participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference
- Personalis Pioneers Advancement in MRD Testing with the Launch of its Real-Time Variant Tracker™
- Personalis Reports Select Preliminary Fourth Quarter and Full Year 2025 Results and Recent Highlights
- Personalis Announces New Publication Applying Ultrasensitive ctDNA Testing to Monitoring Cancer Immunotherapy Response Across Solid Tumors
- New Publication Demonstrates the Importance of NeXT Personal Ultrasensitive Detection of Residual Disease in Lung Cancer
- Personalis to Participate in the Piper Sandler 37th Annual Healthcare Conference
More ▼
